Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
Novel peptides that inhibit the release of microparticles from cells are disclosed. The peptide contains at least one VGFPV motif at the N-terminal and has a length of 10-100 amino acids. Also disclosed is polynucleotide encoding the peptide, expression vectors carrying the polynucleotide, and methods for treating AIDS and tumors using the novel peptides.
1. A peptide for inhibiting the release of microparticles in a cell, said peptide comprising the amino acid sequence of SEQ ID NO: 2 (VGFPVAAVGFPV).
2. The peptide of claim 1 , further comprising at least one SEQ ID NO: 1 motif at the N-terminal.
3. The peptide of claim 1 , further comprising at least one SEQ ID NO: 1 motif at the C-terminal.
4. The peptide of claim 1 , consisting of the sequence VGFPVAAVGFPVDYKDDDDK (SEQ ID NO: 3).
5. A polynucleotide encoding the peptide of claim 1 .
6. The polynucleotide of claim 5 , wherein said peptide comprises the amino acid sequence of SEQ ID NO: 3.
7. An expression vector comprising the polynucleotide of claim 5 operably linked to a regulatory sequence.
8. A pharmaceutical composition comprising:
(1) a peptide comprising the amino acid sequence of SEQ ID NO: 2 or an expression vector encoding such a peptide; and
(2) a pharmaceutically acceptable carrier.
9. The pharmaceutical composition of claim 8 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the N-terminal.
10. The pharmaceutical composition of claim 8 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the C-terminal.
11. The pharmaceutical composition of claim 8 , wherein said peptide comprises the sequence of SEQ ID NO: 3.
12. A method for treating AIDS, comprising:
administering to a subject in need of such treatment an effective amount of a peptide comprising the amino acid sequence of SEQ ID NO: 2.
13. The method of claim 12 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the N-terminal.
14. The method of claim 12 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the C-terminal.
15. The method of claim 12 , wherein said peptide comprises the sequence of SEQ ID NO: 3.
16. A method for treating a tumor, comprising:
administering to a subject in need of such treatment an effective amount of a peptide comprising the amino acid sequence of SEQ ID NO: 2.
17. The method of claim 16 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the N-terminal.
18. The method of claim 16 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the C-terminal.
19. The method of claim 16 , wherein said peptide further comprises the sequence of SEQ ID NO: 3.
20. A method for treating AIDS, comprising:
administering to a subject in need of such treatment an effective amount of an expression vector comprising a polynucleotide encoding a peptide comprising the amino acid sequence of SEQ ID NO: 2 (VGFPVAAVGFPV), wherein said expression vector is capable of expressing said peptide in vivo.
21. The method of claim 20 , wherein said peptide further comprises the amino acid sequence of SEQ ID NO: 3.
22. The method of claim 20 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the N-terminal.
23. The method of claim 20 , wherein said peptide further comprises at least one SEQ ID NO: 1 motif at the C-terminal.